Balakrishna, V. A., Police, A., Hiremath, R., Raj, A., Sulochana, S. P., Chandrasekhar, D. V., Mohd, Z., Bhamidipati, R. K. and Mullangi, R. (2017) “Preclinical assessment of ulixertinib, a novel ERK1/2 inhibitor”, ADMET and DMPK, 5(4), pp. 212–223. doi: 10.5599/admet.5.4.437.